Literature DB >> 10818356

Crystallization and preliminary X-ray analysis of the matrix protein from Ebola virus.

A Dessen1, E Forest, V Volchkov, O Dolnik, H D Klenk, W Weissenhorn.   

Abstract

The matrix protein from Ebola virus is a membrane-associated molecule that plays a role in viral budding. Despite its functional similarity to other viral matrix proteins, it displays no sequence similarity and hence may have a distinct fold. X-ray diffraction quality crystals of the Ebola VP40 matrix protein were grown by the hanging-drop vapour-diffusion method. The crystals belong to the monoclinic space group C2, with unit-cell parameters a = 64.4, b = 91.1, c = 47.9 A, beta = 96.3 degrees. A data set to 1.9 A resolution has been collected using synchrotron radiation. The unit cell contains one molecule of molecular weight 35 kDa per asymmetric unit, with a corresponding volume solvent content of 35%.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818356     DOI: 10.1107/s0907444900004388

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  10 in total

1.  Membrane association induces a conformational change in the Ebola virus matrix protein.

Authors:  S Scianimanico; G Schoehn; J Timmins; R H Ruigrok; H D Klenk; W Weissenhorn
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

2.  Crystal structure of the matrix protein VP40 from Ebola virus.

Authors:  A Dessen; V Volchkov; O Dolnik; H D Klenk; W Weissenhorn
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

3.  Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding.

Authors:  Ziying Han; Hani Boshra; J Oriol Sunyer; Susan H Zwiers; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction.

Authors:  Victoria A Money; Helen K McPhee; Jackie A Mosely; John M Sanderson; Robert P Yeo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

Review 5.  Advances in virus-like particle vaccines for filoviruses.

Authors:  Kelly L Warfield; M Javad Aman
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

6.  Association of ebola virus matrix protein VP40 with microtubules.

Authors:  Gordon Ruthel; Gretchen L Demmin; George Kallstrom; Melodi P Javid; Shirin S Badie; Amy B Will; Timothy Nelle; Rowena Schokman; Tam L Nguyen; John H Carra; Sina Bavari; M Javad Aman
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle.

Authors:  Zachary A Bornholdt; Takeshi Noda; Dafna M Abelson; Peter Halfmann; Malcolm R Wood; Yoshihiro Kawaoka; Erica Ollmann Saphire
Journal:  Cell       Date:  2013-08-15       Impact factor: 41.582

Review 8.  No exit: targeting the budding process to inhibit filovirus replication.

Authors:  Ronald N Harty
Journal:  Antiviral Res       Date:  2008-12-27       Impact factor: 5.970

9.  Molecular Requirements for Self-Interaction of the Respiratory Syncytial Virus Matrix Protein in Living Mammalian Cells.

Authors:  Marta Trevisan; Veronica Di Antonio; Annalisa Radeghieri; Giorgio Palù; Reena Ghildyal; Gualtiero Alvisi
Journal:  Viruses       Date:  2018-03-03       Impact factor: 5.048

10.  Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus.

Authors:  Pierre Becquart; Tanel Mahlakõiv; Dieudonné Nkoghe; Eric M Leroy
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.